Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCPT.L Regulatory News (CPT)

  • There is currently no data for CPT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of subscription and Board changes

17 Feb 2016 16:34

RNS Number : 3828P
Frontier Resources International
17 February 2016
 

For immediate release

 

17 February 2016

 

Frontier Resources International Plc

("Frontier" or the "Company")

Completion of subscription

 and Board changes

 

The Board of Frontier (AIM Ticker: FRI) announces that the direct subscription of 4,750,000,000 new ordinary shares of 0.01p each to raise £1,425,000 before expenses (the "Subscription") completed today and the new shares have been admitted to trading on AIM.

 

In addition, as previously announced, Adam Reynolds has today been appointed to the Board as Chairman of the Company and Jack Keyes and John O'Donovan have ceased to be directors of Frontier.

 

Total voting rights

Following the issue of the Subscription shares, the Company's issued share capital consists of 5,111,999,056 Ordinary Shares, with voting rights. This figure may be used by shareholders in the Company as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

Enquiries:

Frontier Resources International Plc

Adam Reynolds, Chairman

 

Tel: +44 (0) 7785 908158

Beaumont Cornish (Nomad)

Michael Cornish

Emily Staples

 

Tel: +44 (0)20 7628 3396

Beaufort Securities Limited (Broker)

Jon Belliss

 

 

Tel: +44 (0)20 7382 8300

A copy of this announcement is available from the Company's website www.friplc.com

 

APPENDIX

 

The following information is disclosed pursuant to paragraph (g) of Schedule Two of the AIM Rules for Companies:

 

Adam Reynolds, aged 53, has held the following directorships and / or partnerships in the past 5 years:

 

Current:

Past:

Ocutec Eyecare Limited

Bcomp 415 Limited

Premaitha Health plc

Biolustre UK Ltd

Optibiotix Health plc

Wallgate Group plc

Autoclenz Group Limited

Wilton International Marketing Limited

Hubco Investments plc

Alan Bailey (Studios) Limited

Reyco Limited

Hansard Corporate Limited

Medavinci Gold Limited

Chalton Consulting Limited

Emotion Fitness Limited

React Group plc

Orogen Gold plc

Hub Capital Partners Limited

Boldwood Limited

Velvet Consultancy Ltd

EKF Diagnostics Holdings plc

Porta Communications Plc

Autoclenz Holdings Limited

Diablo Consulting Limited

New World Oil & Gas Limited

Bcomp 429 Limited

RNR Holdings Limited

Venn Life Sciences Holdings plc

 

Bcomp 416 Limited

 

Autoclenz Group Limited

 

Wallgate Group plc

Mr Reynolds was appointed as a director of Wallgate Group plc on 3 July 2008 and resigned on 28 November 2008. Wallgate Group plc was put into administration on 12 December 2008 and became subject to creditors' voluntary liquidation on 15 December 2009. The liquidator's statement of receipts of payments to 25 February 2011 showed a creditor shortfall of £419,782.12. Wallgate Group plc was subsequently dissolved on 1 June 2011.

 

Greenhills plc

Mr Reynolds was appointed as a director of Greenhills plc on 22 December 1994. He resigned on 24 January 1996. Greenhills plc was put into receivership on 8 August 1996, and an order to wind the company up was made on 19 February 1997. The receiver's abstract of receipts and payments to 6 July 1998 showed a creditor shortfall of £216,877.32. Greenhills plc was subsequently dissolved on 2 January 2001.

 

Wilton International Marketing Limited

Mr Reynolds was appointed as a director of Wilton International Marketing Limited on 10 June 2005. Wilton International Marketing Limited was put into voluntary liquidation on 14 October 2013 and was subsequently dissolved on 1 August 2014 with no shortfall to creditors.

 

There is no further information to be disclosed in relation to Mr Reynolds pursuant to paragraph (g) of Schedule Two of the AIM Rules for Companies.

 

ENDS

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCAKODNABKDBBD
Date   Source Headline
2nd Dec 20204:25 pmRNSChange of name to MyHealthChecked Plc
2nd Dec 202011:06 amRNSSecond Price Monitoring Extn
2nd Dec 202011:01 amRNSPrice Monitoring Extension
2nd Dec 20207:00 amRNSGenomic testing service launch and Change of name
24th Nov 20204:41 pmRNSSecond Price Monitoring Extn
24th Nov 20204:36 pmRNSPrice Monitoring Extension
23rd Nov 20207:00 amRNSAcquisition of home-use genetic testing company
28th Sep 20207:00 amRNSHalf-year Report
22nd Jul 20207:00 amRNSChange of Adviser
6th Jul 20207:00 amRNSCommercial update; Change of registered office
2nd Jul 20203:24 pmRNSResult of AGM
5th Jun 20207:01 amRNSDirector/PDMR Shareholding
5th Jun 20207:00 amRNSNotice of Annual General Meeting
2nd Jun 20207:00 amRNSCommercial update
29th May 20207:00 amRNSFinal Results
4th May 20207:00 amRNSPartnership agreement with Abingdon Health
27th Apr 20208:16 amRNSDirector/PDMR Shareholding
24th Apr 202011:26 amRNSResult of GM & Completion of Fundraise
14th Apr 20209:27 amRNSHolding(s) in Company
14th Apr 20207:00 amRNSManufacturing outsourcing agreements for myLotus®
8th Apr 20207:00 amRNSPlacing and Subscription to raise £1.9 million
29th Jan 20207:00 amRNSTrading Update
14th Nov 20197:00 amRNSBoard Appointments
13th Nov 20198:35 amRNSBoard changes - replacement
13th Nov 20197:00 amRNSBoard Changes
31st Oct 20197:00 amRNSConcepta announces first myLotus® UK birth
25th Oct 20197:00 amRNSBoard Changes
30th Sep 20197:00 amRNSFirst myLotus® UK Fertility Clinic collaboration
30th Sep 20197:00 amRNSInterim Results
29th Jul 20197:00 amRNSGrant of Options
9th Jul 20197:00 amRNSmyLotus® pregnancies in double figures
13th Jun 20192:01 pmRNSResult of AGM
21st May 20199:00 amRNSNotice of AGM
14th May 20197:01 amRNSAnnual Results
14th May 20197:00 amRNSConcepta announces first myLotus® pregnancies
30th Apr 20194:28 pmRNSHolding(s) in Company
30th Apr 20191:46 pmRNSTR-1: form for notification of major holdings
29th Apr 20191:20 pmRNSTR-1: notification of major holdings
26th Apr 201910:52 amRNSDirector/PDMR Shareholding
8th Apr 20197:00 amRNSPlacing to raise £2.3m; Notice of General Meeting
29th Mar 20197:00 amRNSConcepta to supply myLotus® to Boots UK
12th Mar 20197:00 amRNSConcepta to supply myLotus® to Walgreens Boots
17th Dec 20187:00 amRNSmyLotus® successful UK launch
31st Oct 20187:00 amRNSmyLotus® launch at The Fertility Show, London
29th Oct 20187:00 amRNSmyLotus gains CE-mark regulatory approval
5th Oct 20182:42 pmRNSHolding(s) in Company
28th Sep 20187:00 amRNSGrant of Options
27th Sep 20184:41 pmRNSSecond Price Monitoring Extn
27th Sep 20184:37 pmRNSPrice Monitoring Extension
27th Sep 20187:01 amRNSDirectorate change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.